Search

GI-101

GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation 80 ectodomain as an N-terminal moiety and interleukin-2 variant as a C-terminal moiety

ISB 1342

ISB 1342 is a bispecific antibody simultaneously targeting CD38 and CD3.

Tarlatamab

Tarlatamab is a first-in-class T-cell engager used to treat extensive-stage small cell lung cancer. … [L50748] It is a bispecific monoclonal antibody that targets CD3 expressed on the surface of T-cells and delta-like ligand 3 (DLL3), an inhibitory ligand that suppresses Notch signaling and is highly expressed

Etentamig

TNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.

Cirtuvivint

Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.

Disufenton

NC-6300

NC-6300, also known as K-912, is a novel [epirubicin] drug-conjugated polymeric micelle.

Trimethyltetradecylammonium

Ocaratuzumab

Ocaratuzumab is a humanized monoclonal antibody directed against CD20. It is being investigated for cancers and autoimmune disorders.

LioCyx-M004

LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.